ClinicalTrials.Veeva

Menu

Effectiveness of Intraoperative Cell Salvage in Aseptic Revision Total Hip Arthroplasty.

U

University of Liege

Status

Completed

Conditions

Revision of Total Hip Arthroplasty

Treatments

Procedure: Use of Cell Salvage in revision of total hip arthroplasty

Study type

Observational

Funder types

Other

Identifiers

NCT05237830
Cell-salvage

Details and patient eligibility

About

Intraoperative cell salvage is an important measure of patient blood management but its effectiveness in patients undergoing revision total hip arthroplasty remains unclear. Over the last decade, we have used intraoperative cell salvage systematically in this group of patients. However, since the use of cell salvage has a cost and requires additional resources, we decided to retrospectively investigate its usefulness in this particular indication.

Enrollment

140 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Eligible patients were adults undergoing elective aseptic revision of hip arthroplasty at the department of orthopedic surgery of the University Hospital of Liege between 01 January 2011 and 31 December 2020.

Exclusion criteria

  • Patients undergoing revision for infection or with local malignancies were excluded from this study.

Trial design

140 participants in 2 patient groups

Use
Description:
Patients in whom the cell saver was effectively used
Treatment:
Procedure: Use of Cell Salvage in revision of total hip arthroplasty
Not Use
Description:
Patients in whom the cell saver wasn't effectively used
Treatment:
Procedure: Use of Cell Salvage in revision of total hip arthroplasty

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems